TORONTO, Jan. 2, 2024 /PRNewswire/ – Russel Metals Inc. (TSX: RUS) announces the retirement of Linh Austin from the Board of Directors and the appointment of Stewart Burton as an independent Director. Russel Metals’ Board Chair Jim Dinning extended his appreciation for Mr. Austin’s…
Month: January 2024
SHANGHAI, Jan. 2, 2024 /PRNewswire/ — Pulnovo Medical Limited, a globally recognized device pioneer in the treatment of Pulmonary Hypertension (PH) and Heart Failure (HF), recently announced that it has successfully obtained Humanitarian Use Device (HUD) designation from the US FDA and…
SHANGHAI, Jan. 2, 2024 /PRNewswire/ — Pulnovo Medical Limited, a globally recognized device pioneer in the treatment of Pulmonary Hypertension (PH) and Heart Failure (HF), recently announced that it has successfully obtained Humanitarian Use Device (HUD) designation from the US FDA and…
MICHIGAN CITY, Ind., Jan. 2, 2024 /PRNewswire/ — DwyerOmega, a leading manufacturer and global provider of innovative sensors and instrumentation solutions, today announced the acquisition of substantially all of the assets of Miljoco Corp. LLC (“Miljoco”), including those of Weiss…
MICHIGAN CITY, Ind., Jan. 2, 2024 /PRNewswire/ — DwyerOmega, a leading manufacturer and global provider of innovative sensors and instrumentation solutions, today announced the acquisition of substantially all of the assets of Miljoco Corp. LLC (“Miljoco”), including those of Weiss…
Single-vial thermostabilized bivalent vaccine demonstrates simultaneous protection against two lethal viruses PRINCETON, N.J., Jan. 2, 2024 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and…
Single-vial thermostabilized bivalent vaccine demonstrates simultaneous protection against two lethal viruses PRINCETON, N.J., Jan. 2, 2024 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and…
– Two oral presentations and three poster presentations will highlight Iomab-B and Iomab-ACT CD45 targeted conditioning for bone marrow transplant and CAR-T cellular therapy NEW YORK, Jan. 2, 2024 /PRNewswire/ — Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the…
– Two oral presentations and three poster presentations will highlight Iomab-B and Iomab-ACT CD45 targeted conditioning for bone marrow transplant and CAR-T cellular therapy NEW YORK, Jan. 2, 2024 /PRNewswire/ — Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the…
DUBAI, UAE, Jan. 2, 2024 /PRNewswire/ — Bybit, the world’s third-largest crypto exchange by volume, is proud to announce the outstanding success of its fifth-anniversary celebration event. The #High5Bybit Personality Test and 1-Million USDT Trading Competition captivated the global…